ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

12,908Medicare Part D Prescriptions Filled, Including Refills

Rank: 37 out of 761

$720K Total Retail Price of All Prescriptions

Rank: 40 out of 761

584 Patients Receiving at Least One Drug in Part D
77%Patients 65 Years and Older
39% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Oregon
Lower avg

Schedule Two
Controlled Substances

13% of this provider’s 584 patients filled at least one prescription for a schedule two drug, compared to an average of 9%.

Schedule Three
Controlled Substances

17% of this provider’s 584 patients filled at least one prescription for a schedule three drug, compared to an average of 13%.

Risky Drugs to Seniors

3% of this provider’s 9,719 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

22% of this provider’s prescriptions were for brand-name drugs, compared to an average of 23%.

Prescription Price

$56 was the average price of a prescription from this provider, compared to $54 among peers.

Prescriptions per Patient

22 is the average number of prescriptions (including refills) per patient, compared to an average of 17.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Oregon
LEVOTHYROXINE SODIUM 524 419 1 3
HYDROCODONE-ACETAMINOPHEN 471 344 S3 2 5
LISINOPRIL 416 343 3 1
HYDROCHLOROTHIAZIDE 354 306 4 11
OMEPRAZOLE 347 250 5 4
SIMVASTATIN 307 219 6 2
AMLODIPINE BESYLATE 306 292 7 6
FUROSEMIDE 285 200 8 7
ATENOLOL 281 235 9 8
WARFARIN SODIUM 235 199 10 9
ATORVASTATIN CALCIUM 234 216 11 12
ZOLPIDEM TARTRATE 231 181 12 22
POTASSIUM CHLORIDE 194 135 13 18
METOPROLOL SUCCINATE 194 183 13 16
GABAPENTIN 183 114 15 15
METOPROLOL TARTRATE 170 151 16 14
ALENDRONATE SODIUM 167 158 17 21
LOSARTAN POTASSIUM 163 129 18 13
METFORMIN HCL 155 113 19 10
PRAVASTATIN SODIUM 147 120 20 20
PAROXETINE HCL 146 111 21 47
TRAZODONE HCL 145 78 22 23
CITALOPRAM HBR 126 96 23 19
FENTANYL 124 96 S2 24 57
DIOVAN 121 97 25 58
GLIMEPIRIDE 110 86 26 48
ALLOPURINOL 110 99 26 28
PROMETHAZINE HCL 102 46 R 28 104
ENALAPRIL MALEATE 101 78 29 71
AMITRIPTYLINE HCL 101 77 R 29 54
TRIAMTERENE-HCTZ 99 89 31 42
BUPROPION HCL SR 95 68 32 93
FLUOXETINE HCL 93 85 33 31
PANTOPRAZOLE SODIUM 89 45 34 40
OXYCODONE HCL 85 71 S2 35 24
DONEPEZIL HCL 81 69 36 33
CRESTOR 80 70 37 36
CARVEDILOL 76 60 38 26
CLONIDINE HCL 75 40 39 69
CYMBALTA 74 40 40 53
SERTRALINE HCL 74 67 40 25
FLUTICASONE PROPIONATE 72 46 42 29
LOVASTATIN 71 50 43 17
HYDRALAZINE HCL 71 58 43 114
CYCLOBENZAPRINE HCL 71 15 R 43 51
PREDNISONE 70 64 46 30
POLYETHYLENE GLYCOL 3350 70 48 46 62
TRAMADOL HCL 69 42 48 34
CIPROFLOXACIN HCL 68 62 49 63
RISPERIDONE 68 68 49 83
CLOPIDOGREL 65 58 51 66
NIFEDIPINE ER 64 45 52 128
VENTOLIN HFA 63 32 53 111
QUINAPRIL HCL 63 53 53 156
SPIRONOLACTONE 62 39 55 45
VENLAFAXINE HCL ER 61 26 56 76
LANTUS 57 35 57 41
METHADONE HCL 56 24 S2 58 75
ESTRADIOL 56 53 R 58 80
PREMARIN 54 28 R 60 88
AZITHROMYCIN 51 38 61 70
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on March 10, 2010.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.